Data shown is for informational purposes only and does not constitute investment advice. TopFund is not SEBI-registered. Consult a SEBI-registered advisor before investing.
ICICI Prudential Nifty Pharma Index Fund - Growth
★★★★★ 3rd-party
External rating
- Source: Third-party data provider (Groww/CRISIL)
- Original rating: 2/5, displayed as-is — TopFund does not modify third-party ratings
- Refresh frequency: Whenever TopFund re-syncs this fund's data
- Limitations: The provider's own rating methodology isn't disclosed here — see the provider's own site for their criteria
TopFund Score: 71/100 · Good
How this score is calculated
- Star rating (35%)2/5
- 3Y CAGR (30%)20.83%
- Expense ratio (20%)0.51%
- AUM (15%)₹163 Cr
Not investment advice — an analytical read of public fund data. Methodology →
ICICI Prudential Mutual Fund · Other · Index Funds
₹21.42
AUM: ₹163 Cr
NAV updated about 12 hours ago
Plan
Direct
Option
Growth
Risk
High
Expense Ratio
0.51%
Exit Load
Nil
Fund Manager
Nishit Patel
Inception
Dec 2022
Benchmark
NIFTY Pharma Total Return Index
Sharpe Ratio
1.26
Std Dev (1Y)
14.66%
Historical Returns (CAGR)
Annualized trailing returns computed from NAV history — past performance only, not a guarantee of future results.
1m
+10.68%
3m
+7.56%
6m
+13.89%
1y
+24.16%
3y
+20.83%
5y
—
10y
—
since inception
+21.57%
TopFund's Take on ICICI Prudential Nifty Pharma Index Fund - Growth
ICICI Prudential Nifty Pharma Index Fund - Growth holds up reasonably well within the Index Funds category, currently carrying a 2-star rating. TopFund's composite Health Score, which weighs rating, 3-year CAGR, expense ratio and fund size, puts it at 71/100.
Cost: At 0.51%, the expense ratio runs 31% above the Index Funds category average of 0.39%. That gap is worth weighing against the fund's actual performance versus cheaper peers before committing to a long SIP.
Risk-adjusted performance: Over the trailing 1-year period, the fund shows a strong Sharpe ratio of 1.26 — the fund has generated solid returns relative to the volatility it exposed investors to. Separately, annualised volatility of 14.66% is fairly typical for Index Funds funds.
Who should invest: This fund is best suited to cost-conscious investors happy to simply match the market rather than try to beat it. The High risk rating means near-term volatility should be expected — this isn't a fund to check daily.
This is an automated, data-driven analysis based on the fund's own metrics and its category peers — not personalized investment advice. Consult a SEBI-registered advisor before investing.
Sector Allocation
Asset Allocation
Fund Snapshot
Similar Funds
ICICI Prudential CRISIL-IBX AAA Bond Financial Services Index -Dec 2026 Fund- Direct Plan - Growth
ICICI Prudential Mutual Fund
ICICI Prudential Nifty PSU Bond Plus SDL Sep 2027 40:60 Index Fund - Growth
ICICI Prudential Mutual Fund
Kotak Nifty SDL Apr 2027 Top 12 Equal Weight Index Fund-Direct Plan-Growth
Kotak Mahindra Mutual Fund
Edelweiss CRISIL IBX 50:50 Gilt Plus SDL Short Duration Index fund - Direct Plan - Growth
Edelweiss Mutual Fund
Kotak Nifty SDL Plus AAA PSU Bond Jul 2028 60:40 Index Fund Direct Plan - Growth
Kotak Mahindra Mutual Fund
DSP Nifty 50 Equal Weight Index Fund - Direct Plan - Growth
DSP Mutual Fund
Tools & Guides for This Fund
Frequently Asked Questions about ICICI Prudential Nifty Pharma Index Fund - Growth
The current NAV (Net Asset Value) of ICICI Prudential Nifty Pharma Index Fund - Growth is ₹21.42. NAV is updated every business day after market close by AMFI.
1Y: 24.16% · 3Y CAGR: 20.83%
The expense ratio of ICICI Prudential Nifty Pharma Index Fund - Growth is 0.51% per annum. This is the annual fee charged by the fund to manage your investment.
ICICI Prudential Nifty Pharma Index Fund - Growth is managed by Nishit Patel at ICICI Prudential Mutual Fund.
ICICI Prudential Nifty Pharma Index Fund - Growth is classified as a High risk fund. It is suitable for investors with a long-term horizon of 3+ years.
ICICI Prudential Nifty Pharma Index Fund - Growth is a Index Funds fund. SIP suitability depends on your investment goal and risk profile.
You can start a SIP in ICICI Prudential Nifty Pharma Index Fund - Growth with as little as ₹500 per month through most mutual fund platforms. The minimum lump sum investment is typically ₹1,000.
The Assets Under Management (AUM) of ICICI Prudential Nifty Pharma Index Fund - Growth is ₹163 crore. AUM indicates the total market value of assets managed by the fund.
* Past performance is not indicative of future results. Mutual fund investments are subject to market risks.
Discussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
No comments yet — start the discussion.